Amedeo Nuzzo retweeted
P+EV shows promising activity in collecting duct and renal medullary carcinomas! 🧬
We’ve worked hard to get here, and the road is still long.
Proud of our team! 👏
@g_procopio_ @elena_verzoni
#ESMO26 #GUOncology #RareCancers
Amedeo Nuzzo retweeted
What is the current state of independent clinical research in Italy, and where is it heading? Today plenary session @IstTumori explores emerging regulatory frameworks and their implications for clinicians, patients and institutions.
#FICOG #AIFA #IndependentResearch
📚 New in @ASCO Educational Book: “How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer” 🎯
#TesticularCancer #GermCellTumors #GUOnc
ascopubs.org/doi/10.1200/EDB…
🙏 With @nabiladra @DrDarrenFeldman @siadaneshmand, @Noah_Onc @aloktewar @MichaelBasinMD @federicamascaro @giannatempopatr
@ASCO @JCO_ASCO
🧵New commentary in @JCOOP_ASCO on metastatic Renal Cell Carcinoma:
“Never Stop the Pressure” 🔬
Should we keep anti-angiogenic therapy going beyond progression?
We think YES — and here’s why👇
ascopubs.org/doi/pdf/10.1200…
w/ @alerametta @elena_verzoni @g_procopio_
Amedeo Nuzzo retweeted
#ProstateCancer focus at @IstTumori: update on ongoing academic trials by @valentina79g and real-life clinical scenarios presented by @nzzmda, how trials shape everyday decisions. Debate is key to better care.
#ClinicalResearch #Oncology #Genitourinary #ProstateCancer
Amedeo Nuzzo retweeted
How do we actually treat non–clear cell RCC today?
Our practical overview of systemic therapies across rare renal cancer histologies.
tandfonline.com/eprint/FKBUJ…
@g_procopio_ @elena_verzoni @marcos130990 @MelClaps @valentina79g @nzzmda @Simorota6 @elegusma
Glad to speak at the AIFET Congress about therapeutic strategies for hereditary prostate cancer.
A great opportunity to share insights on how genetics is shaping treatment decisions and improving patient care.
@IstTumori
#AIFET #ProstateCancer #Oncology #Genetics
From the clinic to the poster wall 💪 Honored to share our work on elderly germ cell tumors at #ESMO2025!
Huge thanks to @giannatempopatr for her guidance and for making this project possible 🙌
📢 Our case report on metastatic Leydig cell tumor treated with CDK4 inhibition is now published in JCO Precision Oncology!
👉 doi.org/10.1200/PO-25-00290
A collaborative effort with @JCOPO_ASCO @giannatempopatr @nicolanicolai @AndreaNecchi @montypal
Glad to have worked on this with:
@marcobarella @MelClaps @MZimatore58837 @alerametta @marcos130990 @franligorio @elegusma @Simorota6 @g_procopio_
@mauriziocolecchia @SNazzani @DavideBiasoni @tommasocascella @mariocatanzaro @danielerusconi @chiaravela @carlosilvani @fedemanoni
ESMO drop just crashed the site.
Clinicians, researchers, and oncologists everywhere hitting refresh like it’s Taylor Swift ticket day.
Science waits for no server.
#ESMO25 #Oncology #CancerResearch #ESMOAbstracts #ESMOcrash
@alerametta @elegusma @Simorota6 @myESMO @AIOMtweet
